|
US5691196A
(en)
|
1992-12-31 |
1997-11-25 |
American Cyanamid Company |
Recombinant nucleic acid containing a response element
|
|
US5965606A
(en)
|
1995-12-29 |
1999-10-12 |
Allergan Sales, Inc. |
Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
|
|
CA2273288A1
(en)
|
1996-12-19 |
1998-06-25 |
James Joseph Gibbons |
Method of treating or inhibiting neutropenia
|
|
AU9084601A
(en)
|
2000-09-08 |
2002-03-22 |
Massachusetts Inst Technology |
G-csf analog compositions and methods
|
|
US7119061B2
(en)
|
2002-11-18 |
2006-10-10 |
Vicuron Pharmaceuticals, Inc. |
Dalbavancin compositions for treatment of bacterial infections
|
|
AU2003902308A0
(en)
|
2003-05-14 |
2003-05-29 |
Diagnose It Pty Ltd |
A method and system for the monitoring of medical conditions
|
|
WO2004100972A1
(ja)
|
2003-05-16 |
2004-11-25 |
Kyowa Hakko Kogyo Co., Ltd. |
組織破壊を伴う疾患の予防及び／または治療剤
|
|
EP1621191A1
(en)
|
2004-07-29 |
2006-02-01 |
Werner Bollag |
Treatment of inflammatory diseases by RXR Antagonists
|
|
JP2008509928A
(ja)
|
2004-08-13 |
2008-04-03 |
アノーメド インコーポレイテッド |
前駆／幹細胞を動員するためのケモカインの組み合わせ
|
|
RS51506B
(sr)
|
2004-12-02 |
2011-06-30 |
Venus Remedies Limited H. O&R&D. |
Smeše za suzbijanje beta-laktamazom posredovane rezistencije na antibiotike upotrebom inhibitora beta-laktamaze, korisne za injekcije
|
|
WO2006071451A2
(en)
|
2004-12-03 |
2006-07-06 |
The Regents Of The University Of California |
Compounds that prevent macrophage apoptosis and uses thereof
|
|
CN101472572B
(zh)
|
2006-05-16 |
2012-10-10 |
Io治疗有限责任公司 |
Rar拮抗剂或反向激动剂在治疗化学疗法和/或放射疗法副作用中的用途
|
|
MX2009009997A
(es)
|
2007-03-30 |
2009-12-08 |
Tmrc Co Ltd |
Preparacion de la capsula de tamibarotene.
|
|
JP2011505386A
(ja)
|
2007-12-06 |
2011-02-24 |
シーエスエル、リミテッド |
白血病性幹細胞の阻害方法
|
|
US8580516B2
(en)
*
|
2008-09-05 |
2013-11-12 |
University Of Chicago |
Methods and compositions for direct detection of DNA damage
|
|
AU2010309388B2
(en)
|
2009-10-19 |
2016-03-10 |
Laila Nutraceuticals |
Extracts, fractions and compositions comprising acetogenins and their applications
|
|
RU2446173C1
(ru)
|
2010-08-13 |
2012-03-27 |
Зао "Биокад" |
Новый функционально активный, высокоочищенный стабильный конъюгат гранулоцитарного колониестимулирующего фактора (г-ксф) с полиэтиленгликолем с пролонгированным биологическим действием, пригодный для медицинского применения, и иммунобиологическое средство на его основе
|
|
CN102380090A
(zh)
*
|
2010-08-31 |
2012-03-21 |
健能隆医药技术（上海）有限公司 |
G-csf二聚体在治疗嗜中性粒细胞减少症中的应用
|
|
WO2012109208A2
(en)
|
2011-02-08 |
2012-08-16 |
Cellular Dynamics International, Inc. |
Hematopoietic precursor cell production by programming
|
|
EP2847198B1
(en)
|
2012-05-08 |
2016-12-14 |
Lycera Corporation |
Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of ror-gamma and the treatment of disease
|
|
US20150147309A1
(en)
|
2012-06-06 |
2015-05-28 |
Fondazione Telethon |
Allosteric chaperones and uses thereof
|
|
EP2858636B1
(en)
|
2012-06-07 |
2018-09-05 |
Childrens Hospital Los Angeles |
Methods for treating neutropenia using retinoid agonists
|
|
US20160172942A1
(en)
|
2013-07-04 |
2016-06-16 |
Linak A/S |
Actuator system
|
|
MX2016010699A
(es)
|
2014-02-18 |
2017-10-11 |
Children's Hospital Los Angeles |
Composiciones y metodos para tratar neutropenia.
|